In vitro Activity of Rifaximin, Metronidazole and Vancomycin against Clostridium difficile and the Rate of Selection of Spontaneously Resistant Mutants against Representative Anaerobic and Aerobic Bacteria, Including Ammonia-Producing Species

Publisher： Karger

E-ISSN： 1421-9794|46|4|253-266

ISSN： 0009-3157

Source： Chemotherapy, Vol.46, Iss.4, 2000-06, pp. : 253-266

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacodynamic Studies of Vancomycin, Metronidazole and Fusidic Acid against Clostridium difficile

By  

Chemotherapy, Vol. 53, Iss. 4, 2007-06 ,pp. : 267-274

Karger

Access to resources Recommend Favorite

Activity of Nadifloxacin (OPC-7251) and Seven Other Antimicrobial Agents against Aerobic and Anaerobic Gram-Positive Bacteria Isolated from Bacterial Skin Infections

By  

Chemotherapy, Vol. 50, Iss. 4, 2004-10 ,pp. : 196-201

Karger

Access to resources Recommend Favorite

Comparative in vitro Activity of Vancomycin and Other Antimicrobial Agents against Methicillin-Resistant Staphylococcus aureus and Enterococcus faecium in the Tohoku District of Japan

By  

Chemotherapy, Vol. 44, Iss. 5, 1998-08 ,pp. : 318-323

Karger

Access to resources Recommend Favorite

In vitro Activity of Levofloxacin against Gram-Positive Bacteria

By  

Chemotherapy, Vol. 45, Iss. 6, 1999-11 ,pp. : 411-417

Karger

Access to resources Recommend Favorite

Time-Kill Studies of Antimicrobial Combinations Including Cefotaxime, Ceftriaxone, Vancomycin and Meropenem against Cephalosporin-Resistant Streptococcus pneumoniae

By  

Chemotherapy, Vol. 46, Iss. 5, 2000-08 ,pp. : 303-308

Karger

Access to resources Recommend Favorite